e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Aspects of diagnosis - biology and infections in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The contribution of quantitative determinations through HPLC (high performance liquid chromatography), of the antituberculosis drugs in serum, in prevention of relapses
D. Garbulet, A. Tomosoiu (Iasi, Romania)
Source:
Annual Congress 2004 - Aspects of diagnosis - biology and infections in tuberculosis
Session:
Aspects of diagnosis - biology and infections in tuberculosis
Session type:
Thematic Poster Session
Number:
3923
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Garbulet, A. Tomosoiu (Iasi, Romania). The contribution of quantitative determinations through HPLC (high performance liquid chromatography), of the antituberculosis drugs in serum, in prevention of relapses. Eur Respir J 2004; 24: Suppl. 48, 3923
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Comparison of DNA strip assay and high performance liquid chromatography (HPLC) analysis of mycolic acids for identification of mycobacterial isolates to the species level
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Quantitation method for colistimethate sodium in pharmaceutical aerosol samples using high performance liquid chromatography (HPLC)
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Quantitative determination of terbinafine (anti-aspergillar drug ) in human plasma and lung tissue by gas-chromatography and mass spectometry (GC-MS)
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002
Desmosine as a biomarker of elastin degradation in COPD: current status and future directions
Source: Eur Respir J 2008; 32: 1146-1157
Year: 2008
Multicapillary ion mobility spectrometry (MCC-IMS) for early identification of bacteria in vitro
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Linezolid penetrates in human pleural cavity: A pilot study using ultra-high pressure liquid chromatography in tandem with mass spectrometry (UPLC-MS/MS)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
A liquid chromatography MS/MS metabolomics study of COPD patients
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Measurement of urinary total desmosine and isodesmosine using isotope-dilution liquid chromatography-tandem mass spectrometry
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
A new possibility of process monitoring in lung cancer: Volatile organic compounds detected with ion mobility spectrometry to follow the success of the therapeutic process
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
A case of liquid paraffin pneumonia (pulmonary paraffinoma) defined by gaschromatography-mass spectrometry
Source: Eur Respir J 2001; 18: Suppl. 33, 221s
Year: 2001
A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
Influence of pre analytical and analytical variables in extraction, amplification and detection of
M. tuberculosis
in pleural fluid
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Metabolic profiling detects biomarkers of protein degradation in COPD patients
Source: Eur Respir J 2012; 40: 345-355
Year: 2012
Standardization procedures for in-vitro measurements using differential ion mobility spectrometry (DMS)
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Methodological issues of sample collection and analysis of exhaled breath
Source: Eur Respir Monogr 2010; 49: 96-114
Year: 2010
Pharmacoeconomic aspects of drug susceptibility testing of M. tuberculosis using automated liquid culture systems and solid media
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Detection of lung cancer using ion mobility spectrometry in Japan: A pilot study
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012
Performance of a commercial IFN-γ blood assay for monitoring treatment efficacy in active pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept